Zedoresertib

N/A

Report date: 2026/05/05 20:00:16
NME

Base Information

Drug NameZedoresertib
Drug Alias NameDebio-0123
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerine/threonine-protein kinase WEE1 inhibitors
TargetsSerine/threonine-protein kinase WEE1
Therapy Area/IndicationsSolid tumoursSmall Cell Lung CarcinomaBreast Neoplasms +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesNetherlandsSwitzerland +[5] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAlmac Discovery Ltd
China Registration ClassN/A

Develop Information

Active CompaniesDebiopharm International Sa
Inactive CompaniesN/A
Active IndicationsSolid tumoursBreast NeoplasmsGlioblastoma +[4] 
Inactive IndicationsSmall Cell Lung Carcinoma

Other Information

ATC CodeN/A
Related LinksN/A